Overall rank by patents
#24,308
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 22 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Ezaki holds 11 US patents across 22 technology areas, rank #24,308 of 50,000 tracked assignees.
Ezaki Glico Co. Ltd. has been granted 11 US utility patents between 2015 and 2024, placing Ezaki Glico Co. Ltd. at rank #24,308 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Ezaki Glico Co. Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Ezaki sits between Everbridge, Inc. (11 patents, rank #24,304) and Fibertex Personal CARE A/s (11 patents, rank #24,312) - the closest US assignees by grant volume. The composite Innovation Score of 35.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 8 in the 2015–2019 window, a -62% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ezaki Glico Co. Ltd.'s 13.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ezaki Glico Co. Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Everbridge, Inc.
11 patents
Evolv Technologies, Inc.
11 patents
Exinda Networks PTY, Ltd.
11 patents
ExlService Holdings, Inc.
11 patents
F-star Therapeutics Limited
11 patents
FAMILY INADA CO., LTD.
11 patents
FIBERHOME TELECOMMUNICATION TECHNOLOGIES CO., LTD
11 patents
FIBERTEX PERSONAL CARE A/S
11 patents
Ezaki Glico Co. Ltd.
11 patents
What this shows Ezaki holds 11 patents at rank #24,308, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ezaki's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 27.3% |
| 2016 | 1 | 9.1% |
| 2017 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2019 | 2 | 18.2% |
| 2020 | 1 | 9.1% |
| 2021 | 1 | 9.1% |
| 2024 | 1 | 9.1% |
Top 15 of 22 technology areas
Overall rank by patents
#24,308
Across all tracked assignees
35.1 out of 100
How to use this portfolio
Ezaki's 11 grants land it in the top 50% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.